8月21日晚间，"滋补养生第一品牌"东阿阿胶（000423）发布2025年半年报，业绩整体稳健增长，经营 性现金流与一季度相比有明显改善。 具体来看，报告期内东阿阿胶实现营业收入30.51亿元，同比增长11.02%；归属于上市公司股东的净利 润8.18亿元，同比增长10.74%；归属于上市公司股东的扣除非经常性损益的净利润7.88亿元，同比增长 12.58%；经营活动产生的现金流量净额9.65亿元，同比增长4.70%。 作为一家中华老字号企业，东阿阿胶始创于1952年，1996年在深交所挂牌上市，2005年加入华润（集 团）有限公司。其主要从事阿胶和阿胶系列及其他中成药等产品的研发、生产和销售，是阿胶行业标准 制定的引领者，是滋补健康引领者和中药企业高质量发展的典范。 近些年，为进一步巩固行业地位、拓展增长空间，东阿阿胶持续推进内部改革与战略升级。公司 以"1238"战略为指引，深化推进胶类产业链"三产融合"协同发展，继续做强做优做大阿胶主业，精准拓 深基石业务，统筹拓展潜力产品，着力培育外延品种。其中，以"皇家围场1619"等品牌为代表的"第二 增长曲线"不断拓展滋补领域边界，为大健康行业的发展探索全新方向 ...

Group 1: Share Repurchase and Market Strategy - The company plans to continue researching share repurchase as a tool for market confidence and stock price stability, focusing on high dividend payouts as a primary investor return method [1] - The company aims to enhance brand engagement with younger consumers through product innovation and cultural initiatives, including the launch of convenient packaging and live streaming for targeted outreach [1] Group 2: Water Source Protection - The local government prioritizes the protection of the underground water source, which is rich in trace elements, ensuring high-quality and sustainable water supply through strict testing [2] Group 3: Pricing and Product Strategy - A systematic pricing governance plan is being implemented to create a sustainable pricing ecosystem for core products, transitioning from reliance on price increases to structural growth [3] - The company will dynamically adjust product prices based on supply and demand, optimizing pricing mechanisms for different consumer habits and product innovations [6] Group 4: Management and Strategic Execution - The management team will remain stable and committed to executing the "1238" strategy for steady business development [4] Group 5: Raw Material Supply Assurance - A dual-circulation raw material supply system is established, ensuring stable supply from domestic and international sources, while enhancing the utilization rate of donkey skin through research collaborations [5] Group 6: New Product Development - The company is focusing on the "Muntjac deer industry" and "Cistanche development" as new product directions, aiming for growth in high-potential segments [7]

Group 1: Future Business Strategy - Dong-E E-Jiao will adhere to the "1238" strategy, focusing on the integration of the gelatin industry chain and enhancing its core business [1] - The company aims to improve digital capabilities and drive high-quality growth, aspiring to become a trusted leader in health supplements [1] Group 2: Investment and Acquisition Plans - Investment and acquisitions are key components of the "1238" strategy, with a focus on potential targets in the health supplement sector [1] - The company is implementing a "dual-wheel drive" strategy for investment direction, particularly in pharmaceuticals and health consumer products [2] Group 3: Raw Material Supply Assurance - The company emphasizes the sustainable supply of donkey hide, focusing on both domestic and international markets [3] - Efforts include establishing a supply network and promoting policy guidance in key countries to ensure a stable supply chain [3] Group 4: New Product Development - The "Zhuangben" brand will focus on upstream material acquisition and introduce innovative products to the market [4] - The company plans to enhance brand recognition for "Ejiao Dates" and develop a variety of health snack products [4] - A new category for "Ejiao Bird's Nest" will be created, with a focus on brand optimization and product efficacy verification [4] Group 5: Profit Distribution and Dividends - Since its listing in 1996, the company has distributed dividends 26 times, totaling 8.469 billion yuan, with an average payout ratio of 65.75% [6] - For 2024, the company plans to distribute 818 million yuan, with a payout ratio of 99.87% [6] Group 6: Revenue Projections - In 2024, Dong-E E-Jiao block products are expected to account for approximately 45% of total revenue, while compound Ejiao syrup is projected to contribute nearly 35% [6] Group 7: Brand Development Initiatives - The "Royal Weichang 1619" brand aims to establish itself as a leading men's health brand, focusing on product and category expansion [7] - The "Peach Blossom Princess Ejiao Cake" brand will undergo a comprehensive brand renewal to capture the mainstream beauty market [7] Group 8: Financial Performance Insights - The company experienced a decline in cash flow and an increase in accounts receivable due to strategic credit management and increased procurement of raw materials [8]

Group 1: Company Strategy and Market Position - In 2025, Dong'e Ejiao will focus on the "1238" strategy, emphasizing "growth and breakthrough" as its operational theme, and will implement the "four remakes" to enhance the entire gelatin industry chain [1] - The company holds a combined market share of 38.1% in the Qi and Xue supplement category, with Dong'e Ejiao block at 67.3% and Compound Ejiao Syrup at 31.9% [2] - Dong'e Ejiao aims to strengthen its core business and expand potential products through differentiated innovation and the establishment of technological barriers [1][2] Group 2: Financial Performance and Revenue - In Q1 2025, the company achieved online revenue of approximately 340 million yuan, a year-on-year increase of about 20% [2] - The online revenue breakdown includes: Ejiao block at approximately 120 million yuan (up nearly 15%), Compound Ejiao Syrup at approximately 60 million yuan (up nearly 60%), and Ejiao powder at approximately 60 million yuan (up nearly 50%) [2] - The overall gross margin is maintained at around 70%, with a slight increase in Q1 due to reduced costs from centralized procurement [7] Group 3: Inventory and Sales Management - The reasonable inventory level for Dong'e Ejiao block and Compound Ejiao Syrup is set at six months of terminal market sales, while for Taohua Ji Ejiao cake, it is 1.5 months [2] - The current channel inventory is at a healthy level, and terminal pure sales are progressing steadily [2] Group 4: Future Plans and Dividends - Since its first dividend in 1999, the company has distributed a total of 8.469 billion yuan over 26 occasions, with an average payout ratio of 65.75% [6] - The proposed dividend for 2024 is 818 million yuan, with a payout ratio of 99.70% [6] - The company plans to maintain a stable and proactive dividend policy based on its operational development, profitability, cash flow, and shareholder interests [6] Group 5: Challenges and Adjustments - The increase in accounts receivable in Q1 2025 is attributed to the implementation of a credit management strategy and increased procurement costs for strategic materials [4] - The company is addressing the small proportion of insurance payments for Compound Ejiao Syrup and aims for sustainable growth in this area [5]